Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect

U.S. Food and Drug Administration sent this bulletin at 07/07/2023 11:46 AM EDT

If your email program has trouble displaying this email, view as a webpage.

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect

FOR IMMEDIATE RELEASE - Mumbai, India July 6, 2023/ New Jersey, USA July 6, 2023 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.

Sr. No.	Product Name	Batch No.	Expiry Date
1.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20045	Nov.2023
2.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20055	Nov.2023
3.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20056	Nov.2023
4.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20057	Nov.2023
5.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20059	Nov.2023
6.	Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)	IB20072	Nov.2023

Manage Subscriptions | Unsubscribe All | Help